Abbott Laboratories (SWX:ABT)
Switzerland
· Delayed Price · Currency is CHF 93.50
0.00 (0.00%)
Sep 30, 2024, 9:05 AM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Established Pharmaceutical Products | 5.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Established Pharmaceutical Products Growth | 2.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutritionals | 8.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutritionals Growth | 2.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics | 9.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Growth | -3.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Devices | 18.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Devices Growth | 11.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment | 16.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Growth | 14.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -3.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Established Pharmaceutical Products Operating Earnings | 1.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Established Pharmaceutical Products Operating Earnings Growth | 7.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutritionals Operating Earnings | 1.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutritionals Operating Earnings Growth | 14.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Earnings | 2.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Earnings Growth | -13.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -3.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Devices Operating Earnings | 6.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Devices Operating Earnings Growth | 14.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -3.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 16.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 8.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany | 2.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 2.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India | 1.82B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Switzerland | 1.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Switzerland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 1.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Netherlands | 1.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Netherlands Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
All Other Countries | 14.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
All Other Countries Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Organic Sales Growth | 9.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|